Pharma and biotech companies looking to perform clinical trials in Eastern Asia and Central Asia may want to consider alternatives as the Russia–Ukraine War continues. Georgia and Kazakhstan, for instance, could be new venues for life science companies looking to conduct clinical trials.  Russia and Ukraine both had strong clinical trial growth before 2022 Before…